D-Wave has transitioned from proof-of-concept to large-scale commercial quantum deals, securing major contracts and accelerating revenue growth. QBTS's acquisition of Quantum Circuits, Inc. positions ...
Britney Spears has sold her song catalog and an unclear number of other rights to Primary Wave, two sources confirm to Variety. Reps for both Spears and Primary Wave declined Variety‘s requests for ...
Sources confirm the superstar sold her rights to a catalog that includes iconic tracks like "Oops! … I Did It Again" and "… Baby One More Time." By McKinley ...
Britney Spears has sold her music catalog, though the details of the sale are unclear. USA TODAY has learned that Spears, 44, sold her catalog to music publisher Primary Wave. Citing legal documents ...
Joshua started at GameRant in 2017 where he fell in love with a company that supports creativity, treats video games with the respect they deserve, and is complete with people whose passions match his ...
A microscopic clump of sodium has become the largest object ever to be observed as a wave, improving upon previous records by thousands of atoms. Quantum physics defines particles in terms of waves, ...
WASHINGTON — President Donald Trump sounded the alarm on the eve of the special election runoff for a state Senate seat in Texas. "Make a plan to GET OUT AND VOTE," Trump wrote in a Friday, Jan. 30 ...
A newly detected gravitational wave, GW250114, is giving scientists their clearest look yet at a black hole collision—and a powerful way to test Einstein’s theory of gravity. Its clarity allowed ...
Wave Life Sciences has the fate of its lead RNA editing candidate back in its own hands. Partner GSK has decided not to take over development of WVE-006, an experimental oligonucleotide for alpha-1 ...
Florida Atlantic University is investing $20 million to install a D-Wave quantum supercomputer on its Boca Raton campus. Quantum computing company D-Wave is relocating its headquarters from California ...
GSK has given away rights to the most advanced RNA editing medicine in clinical testing. The drug’s developer, Wave Life Sciences, said Monday it reached a deal with GSK to reclaim global rights to ...